Date | Name | Title | Action | No Shares | Price Per Share |
---|---|---|---|---|---|
Insider Transactions For AORT | |||||
2025-08-27 | Stanton, Marshall S. | SVP, Clinical & MD Affair | Purchased | 18200 | $11.03 |
2025-08-27 | Stanton, Marshall S. | SVP, Clinical & MD Affair | Sold | 18200 | $44.02 |
2025-08-27 | Stanton, Marshall S. | SVP, Clinical & MD Affair | Sold | 18200 | $0.00 |
2025-08-25 | Holloway, Jean F | SVP, General Counsel | Purchased | 10000 | $11.03 |
2025-08-25 | Holloway, Jean F | SVP, General Counsel | Sold | 10000 | $44.37 |
2025-08-25 | Holloway, Jean F | SVP, General Counsel | Sold | 10000 | $0.00 |
2025-08-15 | Mackin, James P | President & CEO | Sold | 12500 | $42.32 |
2025-08-12 | Holloway, Jean F | SVP, General Counsel | Purchased | 16975 | $26.24 |
2025-08-12 | Holloway, Jean F | SVP, General Counsel | Sold | 16975 | $0.00 |
2025-08-12 | Davis, John E | Chief Commercial Officer | Sold | 10802 | $43.67 |
2025-08-12 | Davis, John E | Chief Commercial Officer | Purchased | 10802 | $26.24 |
2025-08-12 | Davis, John E | Chief Commercial Officer | Sold | 10802 | $0.00 |
2025-08-12 | Holloway, Jean F | SVP, General Counsel | Sold | 6381 | $43.02 |
2025-08-12 | Holloway, Jean F | SVP, General Counsel | Sold | 16975 | $43.01 |
2025-08-08 | Horton, Amy | VP, Chief Accounting Officer | Sold | 7992 | $38.49 |
2025-08-08 | Horton, Amy | VP, Chief Accounting Officer | Purchased | 7992 | $29.62 |
2025-08-08 | Horton, Amy | VP, Chief Accounting Officer | Sold | 7992 | $0.00 |
2025-06-17 | Stanton, Marshall S. | SVP, Clinical & MD Affair | Sold | 1236 | $29.50 |
2025-06-17 | Stanton, Marshall S. | SVP, Clinical & MD Affair | Sold | 13764 | $29.50 |
2025-06-13 | Stanton, Marshall S. | SVP, Clinical & MD Affair | Sold | 8747 | $28.46 |